Microsoft To Get 4% Stake, 10-Year Partnership In $2.8B Deal With London Stock Exchange: What You Should Know
December 12, 4:44 AM
Microsoft Corp.
Billionaire John Textor Expects To Close $846M Olympique Lyonnais Deal By Dec. 19
December 11, 1:44 PM
Billionaire and Du Pont family member John Textor is set to officially take over Olympique Lyonnais (OL), or the Lyon football club, for $846 million.
The deal comes at a time of intense bidding across the sport, due to the influx of deep-pocketed American investors.
Erasca Oulicenses Its Mid-Stage Cancer Program To Novartis, Raises $100M Via Equity Offering
December 9, 11:00 AM
Erasca Inc (NASDAQ:ERAS) has entered into an exclusive worldwide license agreement with Novartis AG (NYSE:NVS) for naporafenib, a Phase 2 pivotal-ready pan-RAF inhibitor…
Chart Industries Raises Funds Via Equity & Debt Offerings To Fund Howden Deal
December 9, 10:23 AM
Chart Industries Inc (NYSE:GTLS) has priced its previously announced concurrent offering of 5.9 million shares at a public offering price of…
Autolus Therapeutics’ Leukemia Trial Meets Primary Goal Of Remission Rate, Shares Fall After $150M Capital Raise
December 9, 8:43 AM
Autolus Therapeutics plc’s (NASDAQ:AUTL) Phase 2 pivotal FELIX trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic…
Elon Musk Tweeted Late Friday: When there are macroeconomic risks, it is generally wise to avoid using margin loans on any company, as stocks may move in ways that are decoupled from their long-term potential
December 9, 6:15 AM
https://www.twitter.com/i/status/1601075815927554048
Bloomberg Reported Late Wednesday Elon Musk’s Bankers are Considering Providing New Margin Loans Backed by Tesla Stock to Replace Some of the High Interest Debt on His Twitter Deal
December 8, 6:20 AM
https://www.bloomberg.com/news/articles/2022-12-08/musk-bankers-mull-tesla-margin-loans-to-cut-risky-twitter-debt
Small Biotechs Are Pulling Public Offerings, IPOs Amid ‘Current Market Conditions’
December 7, 3:37 PM
RNA biotech TransCode Therapeutics Inc (NASDAQ:RNAZ) withdrew its S-1 filing with the SEC that it made in late November. TransCode said…